NBIX - Why Is Neurocrine Biosciences Shares Trading Higher Today? | Benzinga
Neurocrine Biosciences Inc (NASDAQ: NBIX) released topline data from the Phase 3 CAHtalyst Pediatric Study of crinecerfont in children and adolescents with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
CAH is an inherited condition that affects the body's adrenal glands, the cone-shaped organs on top of the kidneys. In a person with CAH, the ...